Professor Friedman is ABIM board-certified in cardiovascular medicine and cardiac electrophysiology.  He is a trained electrical engineer, with deep experience in innovation (> 40 patents issued, named Minnesota Top Inventor), and scientific research (> 250 scientific original publications). He is a committed educator, serving as a director for 5 national and international meetings, editor of 7 textbooks, and author of over 60 book chapters. He is a frequent visiting professor and lecturer at educational meetings. 

Professor Friedman has a deep interest in analysis and processing of physiologic signals, remote monitoring, and use of technology including wearable and implantable devices to detect and treat physiologic abnormalities. He leads a team that has been developing artificial intelligence tools to detect and treat cardiovascular disease

In this interview, Professor Friedman talks frankly and pragmatically about the best use of AI in clinical practice. He describes where AI will deliver benefits in primary care and for cardiology specialists in the short and medium term. He is clear too about how to overcome AI scepticism, accelerate AI adoption in early identification of cardiac disease and to  target therapeutic interventions for better patient outcomes and healthcare resource utilisation. 

Rod S Passman, MD  is interviewed by Happitech CEO and Founder Yosef Safi Harb

Rod S Passman, MD is Director, Center for Arrhythmia Research and Jules J. Reingold Professor of Electrophysiology, Professor of Medicine (Cardiology) and Preventative Medicine

An innovator for patients in Atrial Fibrillation, Dr. Passman is a highly regarded cardiac electrophysiologist and is an internationally recognized leader in cardiac monitoring and stroke prevention. 

Dr. Passman pioneered the use of implantable cardiac monitors to search for atrial fibrillation in stroke patients, a strategy now part of standard practice around the world. His current research focuses on implantable and wearable heart monitors to guide the use of anticoagulants in patients with atrial fibrillation.

In this wide-ranging interview Dr Passman describes some of the benefits for patients of the emergence of consumer-style devices for remote patient monitoring.   Dr. Passman also calls for more small-scale research studies, in partnership with the manufacturers of these devices, to evidence their ability to improve patient outcomes and save healthcare costs to encourage reimbursement by Payers.

Professor Helmut Puererfellner, MD, FESC, FHRS  is interviewed by Happitech CEO and Founder Yosef Safi Harb.

Professor Puererfellner is Head of the Department of Electrophysiology and Senior Consultant at Ordensklinikum Linz, Austria.  The department is a well-known institution for the treatment of all kinds of arrhythmias accepting patients from Austria and abroad. Professor Puererfellner is heavily involved in European Heart Rhythm Association (EHRA) since 2011 including a duty as Scientific Program Chair for the Annual Congress and was elected to the Executive Board as Treasurer for 2018-2020,  International Affairs Coordinator 2020-2022 and EHRA President Elect 2022-2024.

Professor Puererfellner has 123 items in PubMed (National Library of Medicine) as of January 2024.

A keen cyclist, singer and lover of music from The Beatles to Bach, Professor Puererfellner reflects on how, in his professional life,  personalised data generated from remote patient monitoring, and implanted and wearable devices can empower patients and democratise medicine but also overwhelm physicians.

Professor Puerfellner describes several initiatives in which he and colleagues in the medical societies, MedTech and software development are working together to agree on standards and a common language to enable the presentation of the right data, from the right population of patients in the right place, at the right time to support clinical decision making and improve patient outcomes. 

Mellanie True Hills is interviewed by Happitech CEO and Founder Yosef Safi Harb

Mellanie True Hills is a heart disease survivor, heart health expert, patient advocate, award-winning author, and founder and CEO of the non-profit American Foundation for Women's Health and StopAfib.org, the world's foremost atrial fibrillation patient advocacy organization. 

In this episode, Mellanie  (or as she dubs herself 'Grandma-gone-digital') brings her passionate patient perspective to the discussion about the benefits of digital technology in managing cardiovascular disease. Quoting from a 2021 survey conducted by  StopAfib.org,  71% of respondents use digital devices of one sort or another to keep track of their health. Mellanie describes how the use of these devices contributes to a sense of control, peace-of-mind, and comfort in managing their condition and helps to inform consultations with their clinicians.

Andrea Russo MD is interviewed by Happitech CEO and Founder Yosef Safi Harb

Dr. Russo is Professor of Medicine at Cooper Medical School of Rowan University, Academic Chief of the Division of Cardiology, Director of Electrophysiology and Arrhythmia Services and Director of the CCEP Fellowship Program at Cooper University Hospital in Camden, N.J. She is a past president of the Heart Rhythm Society (HRS). Her areas of particular research interest include sex differences in arrhythmias, implantable cardioverter defibrillators, atrial fibrillation and digital health

In this episode, Andrea describes her experience of introducing remote patient monitoring (RPM) to her patients and into her hospital team's practice.  Andrea also describes what success looks like for patients and clinicians; introduced to new ways of working with digital health tech and wearables etc. 

Joshua Lampert is interviewed by Happitech CEO and Founder Yosef Safi Harb

Joshua is  Electrophysiology Fellow at Mount Sinai Hospital, USA. Joshua has a research focus on machine learning, model explainability and novel technologies. 

In this episode, Joshua  shares his thoughts about the benefits for patients of remote patient monitoring (RPM) in cardiovascular disease and highlights too, some of the challenges of introducing RPM for both patients and the hospital team.  Joshua also discusses the use of AI and machine learning in the future of cardiology care.